WHO & UNICEF Boost For COVID-19 Vaccine Supply In Poorer Countries
Two Versions Of AZ Product OKd For Emergency Use
While wealthier countries are able to secure plentiful vaccine supplies, a huge effort will be needed to ensure that people in less well off regions of the world get their fair share. The WHO says the AstraZeneca vaccine should be used in the over-65s and in countries with variants of the virus.
You may also be interested in...
Coronavirus Notebook: EMA Issues Guidance On Development Of Variant Vaccines, EU Leaders Urge Production Ramp-Up
A batch of AstraZeneca/Oxford University coronavirus vaccines has arrived in Ghana, the first country in the world to receive vaccines via the COVAX Facility.
Coronavirus Update: Pfizer Pledges To Double US Vaccine Output
A round-up of the latest developments, including Celltrion’s new antibody cocktail and SK Biosience and Novavax expanding their collaboration.
Coronavirus Notebook: UK Pledges To Donate Surplus Vaccines, UN Chief Wants Global Vaccination Plan
Janssen-Cilag has asked for a WHO Emergency Use Listing for its vaccine candidate, while azelastine and carrageenan are both showing promise as potential treatments for COVID-19.